Public consultation on interim decisions to amend the Poisons Standard - ACCS & Joint ACMS-ACCS - MARCH, 2025

Feedback updated 14 Oct 2026

We asked

From 18 December 2025 to 23 January 2026, we sought submissions from the public on the Delegate’s interim decisions previously discussed at the March 2025 meetings of the Advisory Committees on Medicines and Chemicals Scheduling. Respondents were given the choice to indicate their support or opposition to the interim decisions using survey buttons, with or without a written response. 

You said

We received a total of 8 submissions in response to the interim decision for March 2025, 1 of which was from an individual and 5 from organisations. The breakdown of the responses has been provided below:  

 

MEDIUM AND LONG CHAIN (C6-15) ALKYL SULFATES: A total of 2 votes were received for MEDIUM AND LONG CHAIN (C6-15) ALKYL SULFATES, none in full support, none in partial support and 2 in opposition of the interim decision. Of these submissions, both provided a written response.  

 

SODIUM HYDROXIDE and POTASSIUM HYDROXIDE: A total of 7 votes were received for SODIUM HYDROXIDE and POTASSIUM HYDROXIDE, 7 in full support, none in partial support and none in opposition of the interim decision. Of these submissions, 5 provided a written response.  

 

METHYL ETHYL KETONE OXIME: A total of 4 votes were received for METHYL ETHYL KETONE OXIME, 2 in full support, 2 in partial support and none in opposition of the interim decision. Of these submissions, all provided a written response, with 2 in support, 2 in partial support and none in opposition.  

 

ACRYLATES AND METHACRYLATES BASED ON BISPHENOL A (BPA): No votes were received for ACRYLATES AND METHACRYLATES BASED ON BISPHENOL A (BPA).  

 

CYANOACRYLATE ESTERS: A total of 2 votes were received for CYANOACRYLATE ESTERS, 1 in full support, 1 in partial support and none in opposition of the interim decision. Of these submissions, 2 provided a written response, 1 written response in support, 1 written response in partial support and none in opposition.  

 

CHROMIUM-DL-METHIONINE (CHROMIUM ORGANIC CHELATES): A total of 2 votes were received for CHROMIUM-DL-METHIONINE (CHROMIUM ORGANIC CHELATES), 2 in full support, none in partial support and none in opposition of the interim decision. Of these submissions, 1 provided a written response in support.  

We did

The Delegate considered all submissions prior to making a final decision on these interim decisions. The final decisions on the proposed amendments to the Poisons Standard were published on 25 May 2026.

Published responses

View submitted responses where consent has been given to publish the response.

Closed 23 Jan 2026

Opened 18 Dec 2025

Contact

Medicines Scheduling

1800 020 653

medicines.scheduling@health.gov.au

Overview

Interim decisions regarding substances discussed at the expert advisory meetings. 

This consultation is for interim decisions made in relation to substances that were discussed at the March 2025 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

Kindly note that the interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 23 January 2026. All submissions received by the deadline will be considered by the delegate before they make a final decision.

The interim decisions under consultation are detailed in the Public notice of interim decisions March 2025 which can be accessed below: 

Substances for which public comment is sought:

  • MEDIUM AND LONG CHAIN ALKYL SULFATES
  • SODIUM HYDROXIDE AND POTASSIUM HYDROXIDE
  • METHYL ETHYL KETONE OXIME (MEKO)
  • ACRYLATES AND METHACRYLATES BASED ON BISPHENOL A (BPA)
  • CYRANOACRYLATE ESTERS
  • CHROMIUM DL-METHIONINE (CHROMIUM ORGANIC CHELATES)

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health, Disability and Ageing or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions at a later date.

Audiences

  • Advertisers
  • Aged care professionals
  • Aged care service providers
  • Aged care workforce
  • Biologicals
  • Businesses
  • Commonwealth agencies
  • Community groups
  • Complementary medicines
  • Consumers/Public
  • Contracted Service Providers
  • General public
  • Health professionals
  • Health professionals
  • Health workforce
  • Industry
  • Manufacturers
  • Manufacturers
  • Medical Devices & IVDs
  • Non-government organisations
  • Other
  • Over-the-counter medicines
  • Prescription medicines
  • Sponsors
  • Sponsors
  • State government agencies

Interests

  • Scheduling/Poisons standard